Elia Farah

463 total citations
8 papers, 358 citations indexed

About

Elia Farah is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Elia Farah has authored 8 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Elia Farah's work include Prostate Cancer Treatment and Research (7 papers), Estrogen and related hormone effects (2 papers) and Hormonal and reproductive studies (1 paper). Elia Farah is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Estrogen and related hormone effects (2 papers) and Hormonal and reproductive studies (1 paper). Elia Farah collaborates with scholars based in United States and China. Elia Farah's co-authors include Xiaoqi Liu, Lijun Cheng, Zhuangzhuang Zhang, Nadia A. Lanman, Pete E. Pascuzzi, Sanjay Gupta, Yifan Kong, Jie Li, Nihal Ahmad and Yanquan Zhang and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Oncogene.

In The Last Decade

Elia Farah

8 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elia Farah United States 7 228 187 123 78 40 8 358
Maria V Yusenko Germany 13 375 1.6× 268 1.4× 153 1.2× 71 0.9× 45 1.1× 22 479
Takahiro Narimatsu Japan 9 350 1.5× 123 0.7× 251 2.0× 50 0.6× 28 0.7× 16 442
Julius Semenas Sweden 9 235 1.0× 166 0.9× 114 0.9× 89 1.1× 12 0.3× 14 381
Qiji Li China 9 308 1.4× 112 0.6× 168 1.4× 131 1.7× 16 0.4× 13 450
Kati Kivinummi Finland 9 241 1.1× 205 1.1× 191 1.6× 61 0.8× 13 0.3× 12 383
Fraser Johnson Canada 6 212 0.9× 246 1.3× 91 0.7× 90 1.2× 12 0.3× 10 341
Emma Jernberg Sweden 10 157 0.7× 250 1.3× 114 0.9× 111 1.4× 14 0.3× 12 381
John Shou United States 4 229 1.0× 190 1.0× 115 0.9× 52 0.7× 10 0.3× 8 348
Estelle Li Canada 6 195 0.9× 68 0.4× 76 0.6× 78 1.0× 58 1.4× 11 311
Adrienne R. Hanson Australia 9 241 1.1× 175 0.9× 168 1.4× 106 1.4× 10 0.3× 15 438

Countries citing papers authored by Elia Farah

Since Specialization
Citations

This map shows the geographic impact of Elia Farah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elia Farah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elia Farah more than expected).

Fields of papers citing papers by Elia Farah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elia Farah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elia Farah. The network helps show where Elia Farah may publish in the future.

Co-authorship network of co-authors of Elia Farah

This figure shows the co-authorship network connecting the top 25 collaborators of Elia Farah. A scholar is included among the top collaborators of Elia Farah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elia Farah. Elia Farah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Li, Chaohao, Jinpeng Liu, Daheng He, et al.. (2022). GSTM2 is a key molecular determinant of resistance to SG-ARIs. Oncogene. 41(40). 4498–4511. 6 indexed citations
2.
Zhang, Yanquan, Yifan Kong, Elia Farah, et al.. (2021). Epigenetics in prostate cancer treatment. PubMed. 5. 341–356. 11 indexed citations
3.
Li, Chaohao, Nadia A. Lanman, Yifan Kong, et al.. (2020). Inhibition of the erythropoietin-producing receptor EPHB4 antagonizes androgen receptor overexpression and reduces enzalutamide resistance. Journal of Biological Chemistry. 295(16). 5470–5483. 10 indexed citations
4.
Farah, Elia, Chaohao Li, Lijun Cheng, et al.. (2019). NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells. Journal of Biological Chemistry. 294(21). 8543–8554. 50 indexed citations
5.
Zhang, Zhuangzhuang, Lijun Cheng, Jie Li, et al.. (2018). Inhibition of the Wnt/β-Catenin Pathway Overcomes Resistance to Enzalutamide in Castration-Resistant Prostate Cancer. Cancer Research. 78(12). 3147–3162. 123 indexed citations
6.
Kong, Yifan, Lijun Cheng, Fengyi Mao, et al.. (2018). Inhibition of cholesterol biosynthesis overcomes enzalutamide resistance in castration-resistant prostate cancer (CRPC). Journal of Biological Chemistry. 293(37). 14328–14341. 86 indexed citations
7.
Li, Jie, Ruixin Wang, Yifan Kong, et al.. (2017). Targeting Plk1 to Enhance Efficacy of Olaparib in Castration-Resistant Prostate Cancer. Molecular Cancer Therapeutics. 16(3). 469–479. 43 indexed citations
8.
Chen, Long, Jie Li, Elia Farah, et al.. (2016). Cotargeting HSP90 and Its Client Proteins for Treatment of Prostate Cancer. Molecular Cancer Therapeutics. 15(9). 2107–2118. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026